Advanced Biomedical Technology Inc., the first company in Taiwan, receives the FDA-announced Device Master File registering for biodegradable 3D-printing materials.
Advanced Biomedical Technology Inc. receives Device Master File (MAF) acknowledgment letter from FDA of the MeDFila® PCL-Ceramic 3D printing filament.
Advanced Biomedical Technology Inc. has successfully submitted a Device Master File to the Center for Devices and Radiological Health (CDRH) at the FDA for MeDFila®, their additive manufacturing (AM) PCL-Ceramic printing filament and received an Acknowledgment letter from the FDA confirming submission filing. For the medical device manufacturer, this MAF is now available for reference and review at the FDA.
“This MAF brings the MeDFila® another step closer to becoming the material of choice for medical 3D printing application and custom personal implant,” said Dr. Bruce Chen, CEO. “We will continue to deliver different composite material for medical 3D printing, which is a huge and growing market.”
Advanced Biomedical Technology Inc. shall provide MAF authorization letter on customer requests for their FDA’s review in the context of their product registration.
Formnext is more than an exhibition and conference. It’s an entire platform for companies from the world of additive manufacturing. This year, Advanced Biomedical Technology will show our MeDFila® product portfolio for medical application. Welcome to visit us and find out the potential of biodegradable 3D printing filaments at booth B30E.
Are you planning to go to Formnext, but haven’t registered yet? Contact us to redeem a free of charge entry voucher.
MeDFila® is a brand of biodegradable 3D printing filaments with various composition of materials.
Total Solution for you! We provide materials, printing system, and customized printing service for your innovative medical devices project. Take a look at our products and services.
Our CEO Bruce Chen was invited to give a talk about the application of biodegradable 3DP material for orthopedic implant at Shanghai Ninth People’s Hospital, Shanghai JiaoTong University Schools of Medicine in China.
Shanghai Ninth People’s Hospital is a leading hospital which provides 3D printing medical service to patients. In the meeting, Bruce shared his professional experience and accomplishments in biomaterial and demonstrate the potential application of medical-grade 3D printing filament “MeDFila” for the orthopedic implant. To know more about MeDFila, please visit: MeDFila
The world leading chemical company head into AM field with a strategic partner. It’s shown the great and bright future with AM integration with raw materials supplier. And we both find the image processing and materials property are synergized for better application. See the news”Optimizing materials and software for 3D printing”
As a medical-grade 3D printing material provider, we believe this kind of cooperation will become more and more important, especially in medical application territory.
Additive manufacturing (AM) has become popular and significant potential as a fabrication method in creating different type of scaffold for tissue engineering.A researcher could easy to create a proper structure for a specific purpose by 3D printing. However, to choose a right material with good quality is very important for a successful research. MeDFila is a high-quality biodegradable 3D printing filament as an ideal material to make your scaffold for your tissues engineering research.
Additive Manufacture (AM) process had become popular in medical fields. Especially in the orthopedic field. Our filaments are design for those who are looking for medical-grade 3D printing filament to apply their idea in medical application. To know more about MeDFila please visit MeDFila.